Skip to content
Invitrocue - Transforming bioanalytics
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)

Financial Reports

Appendix 4C – Quarterly Report and Business Update

July 31, 2017

Appendix 4C – Quarterly Report and Business Update Investor Call  

Categories ASX Announcements, Financial Reports

Response to ASX Appendix 4C Query

May 11, 2017

Response to ASX Appendix 4C Query

Categories ASX Announcements, Financial Reports

Appendix 4C – Quarterly Report

April 28, 2017

Appendix 4C – Quarterly report for entities subjected to Listing Rule 4.7B: Download here.

Categories ASX Announcements, Financial Reports

Appendix 4D – Half Yearly Report and Accounts

February 28, 2017

Appendix 4D – Half Yearly Report and Accounts

Categories ASX Announcements, Financial Reports

Appendix 4C – Quarterly Report

January 30, 2017

Appendix 4C – Quarterly report for entities subjected to Listing Rule 4.7B: Download here.

Categories ASX Announcements, Financial Reports

Appendix 4C – Quarterly Report

October 31, 2016

Appendix 4C – Quarterly report for entities subjected to Listing Rule 4.7B: Download here.

Categories ASX Announcements, Financial Reports

Annual Report For The Period Ended 30 June 2016

September 30, 2016

Annual Report Click here to view on ASX. Click here to view on Google Drive.

Categories ASX Announcements, Financial Reports

Preliminary Final Report

August 31, 2016

Preliminary Final Report: Download here.  

Categories ASX Announcements, Financial Reports

Appendix 4C – Quarterly Report

July 28, 2016

Quarterly Report : Appendix 4C

Categories ASX Announcements, Financial Reports

Appendix 4C – Quarterly Report

April 27, 2016

Quarterly Report – Appendix 4C  

Categories ASX Announcements, Financial Reports
Post navigation
Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 Next →

Recent Posts

  • Strategic partnership & Financial advisor appointment
  • Invitrocue announces acquisition of Welala to create life science leadership in Thailand and Asean
  • Invitrocue’s Onco-PDO test is Singapore’s and world’s first validated and approved Clinical Cancer Drug Screening service for Personalised Oncology
  • Operational Updates – February 2024
  • Operational Updates – October 2023

GET IN TOUCH

51 Science Park Road, #01-11/13 The Aries, Singapore Science Park II Singapore 117586

GENERAL / PHARMACOLOGY ENQUIRIES:

+65 6460 0497
contact@invitrocue.com

ONCO-PDO ENQUIRIES:

+65 6819 0181
onco-pdo@invitrocue.com
SAC - SINGLAS Accredited Laboratory

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Logo Invitrocue
Icon-twitter-x Facebook-f Linkedin-in Youtube

© Copyright 2026 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings